Whole exome sequencing identifies RAI1 mutation in a morbidly obese child diagnosed with ROHHAD syndrome.
Vidhu V Thaker, Kristyn M Esteves, Meghan C Towne...
https://pubmed.ncbi.nlm.nih.gov/25781356/Actively Recruiting
Led by Columbia University · Updated on 2025-10-21
12
Participants Needed
2
Research Sites
N/A
Total Duration
ROHHAD syndrome is a rare condition affecting children characterized by rapid onset obesity, central hypoventilation, hypothalamic dysfunction, and autonomic disturbances. Researchers aim to understand the metabolic and genetic changes behind the rapid weight gain and other symptoms in children with ROHHAD syndrome. This observational study focuses on investigating the whole transcriptome profile of hypothalamic neurons derived from patients to explore these underlying mechanisms. The study involves collecting blood samples from children diagnosed with ROHHAD and their unaffected first-degree relatives. These samples will be used to generate patient-specific induced pluripotent stem cell-derived hypothalamic neurons for whole transcriptome profiling. Selected patients may also undergo detailed metabolic testing to better understand the causes of excessive weight gain. Participants will be monitored for changes in the transcriptome profile of hypothalamic cells over a two-year period. Blood samples and clinical data will be collected to analyze the differences between affected children and their relatives. The study will assess transcriptome changes and metabolic features that contribute to ROHHAD syndrome, with no treatment intervention involved. The total duration of participation may vary depending on individual involvement in metabolic phenotyping.
CONDITIONS
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
V
Vidhu Thaker, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Columbia University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants provide blood samples to obtain peripheral mononuclear cells for transcriptome profiling to study hypothalamic cells.
1 visit (in-person)
Duration - Up to 2 years
Participants are observed to compare transcriptome profiles and metabolic phenotyping data over time.
Additional assessments may occur depending on cohort assignment
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Vidhu V Thaker, Kristyn M Esteves, Meghan C Towne...
https://pubmed.ncbi.nlm.nih.gov/25781356/Columbia University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor